Trending...
- Mayor Brandon Johnson Statement On President Trumps Comments About Deploying The National Guard To Chicago - 130
- Connect With Purple Wave Auction At Farm Progress Show - 118
- Premier Lacrosse League Delivers Record Viewership and Engagement in 2025 Regular Season - 115
FAYETTEVILLE, Ark. & AUCKLAND, New Zealand - illiNews -- Lineus Medical is pleased to announce a new distribution agreement with Venture Medical, a 100% New Zealand–owned medical supplier based in Auckland. Venture Medical specializes in vascular access and wound care and will now add Lineus Medical's SafeBreak® Vascular, the only breakaway device for IV lines clinically proven to reduce multiple IV complications, to its portfolio. This partnership expands SafeBreak's availability to hospitals and healthcare providers throughout New Zealand.
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1. SafeBreak is cleared for all vascular lines down to two weeks of age both in the United Sates and Canada.
More on illi News
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks a significant milestone in Lineus Medical's international growth. By partnering with Venture Medical, we are expanding SafeBreak Vascular into a new market and building momentum for broader global adoption. Venture Medical's local expertise and strong customer relationships make them the right partner to drive commercial success in New Zealand."
"Signing this agreement with Venture Medical is an important step in bringing SafeBreak Vascular to in the people of New Zealand.", Vance Clement CEO of Lineus Medical stated. "Our mission is to reduce the "pains" associated with medical lines and make SafeBreak the standard of care globally."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on illi News
References
1. Data on file
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. The separated device also causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patient's infusion is restarted. It's a win-win-win. Patients avoid additional needlesticks, nurses save time, and hospitals save money1. SafeBreak is cleared for all vascular lines down to two weeks of age both in the United Sates and Canada.
More on illi News
- $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space
- United Airlines to Present at the Morgan Stanley's 13th Annual Laguna Conference
- From Overgrown to Oasis- Midwest Homeowners Turn to Custom Pond Builds This Summer
- New Book: Cold War Sci-Fi Thriller Arrives Today
- BeeCool Bikes Unveils Next-Generation "Super Frame" with Bee Defender Series
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks a significant milestone in Lineus Medical's international growth. By partnering with Venture Medical, we are expanding SafeBreak Vascular into a new market and building momentum for broader global adoption. Venture Medical's local expertise and strong customer relationships make them the right partner to drive commercial success in New Zealand."
"Signing this agreement with Venture Medical is an important step in bringing SafeBreak Vascular to in the people of New Zealand.", Vance Clement CEO of Lineus Medical stated. "Our mission is to reduce the "pains" associated with medical lines and make SafeBreak the standard of care globally."
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found on the company website: www.lineusmed.com or you can follow the company on Facebook or LinkedIn.
More on illi News
- University of South Pacific and Battery Pollution Technologies Forge Strategic Partnership to tackle Battery End-of-Life Challenges in the Pacific
- Shincheonji Tanzania Church Holds Revelation Bible Exam with Local Pastors and Believers
- Naperville Man Charged with Armed Carjacking/Kidnapping and Attempt Armed Carjacking at Gunpoint in Two Separate Incidents in Naperville and Warrenville
- Portland Med Spa Expands Service Offerings with Latest Aesthetic Technologies
- ShortTrack Expands Partnership with Qualia
References
1. Data on file
Source: LineusMedical
0 Comments
Latest on illi News
- Fine Arts Festival Downtown Downers Grove
- PermianMuseum.com adds Interstellar Visitor Video Gallery
- SOBREO Elixirs Debut in New York City, Defining a New Era in Inclusive Hospitality
- Allen Field to Showcase Sustainable Paper Handle Applicator at PACK EXPO Las Vegas 2025
- Chicago Paper Artist Janie Flores Joins Illinois Humanities Odyssey Project 2025 Cohort
- How One Missed Mortgage Payment Can Trigger a Chain Reaction — How 4Closure Rescue LLC Helps Stop
- Riverdale receives grant to bring accessibility to Clark Park
- Pure Business Capital Empowering Entrepreneurs: Innovative Funding Solutions Under Mark Shelton
- Laughter, Magic & Mayhem Take Over Las Vegas At Two Hot Locations! Delirious Comedy Club & House of Magic Bring Nonstop Entertainment
- How I Stopped My Little Toe from Stealing the Spotlight
- 3rd Armor Launches #1 Revenue Protection System to Eliminate Pricing Errors and Protect Margins
- New Sci-Fi Crime Novel Immerses Readers in an Increasingly Divided America
- 500% Increase in Revenue for Q2 with Acquisition Plans Including UK Telecom 3D Design/Modeling Company for Global AI Drone & Quantum Computing Leader
- K2 Integrity and Rafidain Bank Launch Strategic Partnership to Strengthen Financial Integrity
- Anern's 2025 Global Energy Journey: Expanding Clean Energy Across Four Continents
- Hydrosome Labs Study Links Ultrafine Bubble Water to Better Gut Health and Lower Inflammation
- STLE Brings Tribology & Lubrication for E-Mobility Conference to Michigan November 19-21
- Joint Venture for Expansion Into Asset-Backed Real Estate; $100 Million Initiative via Offering of Shares at Over $4 for Digital Assets: $OFAL
- Mrs. Field's Closet Expands to Minot North High School
- $1 Billion Revenue Target, $15M EBITDA Run Rate Plan, and a Breakout Moment for This Global Tech Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST):